239 related articles for article (PubMed ID: 21163178)
1. Response to the 2009 influenza A(H1N1) pandemic in Italy.
Rizzo C; Rota MC; Bella A; Giannitelli S; De Santis S; Nacca G; Pompa MG; Vellucci L; Salmaso S; Declich S
Euro Surveill; 2010 Dec; 15(49):. PubMed ID: 21163178
[TBL] [Abstract][Full Text] [Related]
2. Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience.
Gil Cuesta J; Aavitsland P; Englund H; Gudlaugsson Ó; Hauge SH; Lyytikäinen O; Sigmundsdóttir G; Tegnell A; Virtanen M; ; Krause TG
Euro Surveill; 2016 Apr; 21(16):. PubMed ID: 27123691
[TBL] [Abstract][Full Text] [Related]
3. Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13.
Fowlkes A; Steffens A; Temte J; Lonardo SD; McHugh L; Martin K; Rubino H; Feist M; Davis C; Selzer C; Lojo J; Oni O; Kurkjian K; Thomas A; Boulton R; Bryan N; Lynfield R; Biggerstaff M; Finelli L;
Lancet Respir Med; 2015 Sep; 3(9):709-718. PubMed ID: 26300111
[TBL] [Abstract][Full Text] [Related]
4. Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations.
Banzhoff A; Haertel S; Praus M
Hum Vaccin; 2011 May; 7(5):539-48. PubMed ID: 21422814
[TBL] [Abstract][Full Text] [Related]
5. [Pandemic preparedness planning. What did we learn from the influenza pandemic (H1N1) 2009?].
Schaade L; Reuss A; Haas W; Krause G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Dec; 53(12):1277-82. PubMed ID: 21161478
[TBL] [Abstract][Full Text] [Related]
6. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
[TBL] [Abstract][Full Text] [Related]
8. Two waves of pandemic influenza A(H1N1) 2009 in Wales--the possible impact of media coverage on consultation rates, April-December 2009.
Keramarou M; Cottrell S; Evans MR; Moore C; Stiff RE; Elliott C; Thomas DR; Lyons M; Salmon RL
Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262184
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.
Hardelid P; Fleming DM; McMenamin J; Andrews N; Robertson C; SebastianPillai P; Ellis J; Carman W; Wreghitt T; Watson JM; Pebody RG
Euro Surveill; 2011 Jan; 16(2):. PubMed ID: 21251487
[TBL] [Abstract][Full Text] [Related]
10. Contribution of the Portuguese Laboratory Network for the Diagnosis of Influenza A(H1N1)pdm09 infection during the 2009/10 and 2010/11 influenza seasons.
Portuguese Laboratory Network for the Diagnosis of Influenza Infection
Euro Surveill; 2012 Jul; 17(27):. PubMed ID: 22790607
[TBL] [Abstract][Full Text] [Related]
11. Low adherence to influenza vaccination campaigns: is the H1N1 virus pandemic to be blamed?
Trivellin V; Gandini V; Nespoli L
Ital J Pediatr; 2011 Nov; 37():54. PubMed ID: 22074674
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
[TBL] [Abstract][Full Text] [Related]
13. Influenza epidemiology in Italy two years after the 2009-2010 pandemic: need to improve vaccination coverage.
Gasparini R; Bonanni P; Amicizia D; Bella A; Donatelli I; Cristina ML; Panatto D; Lai PL
Hum Vaccin Immunother; 2013 Mar; 9(3):561-7. PubMed ID: 23292210
[TBL] [Abstract][Full Text] [Related]
14. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of hospitalised patients with influenza-like illness during pandemic influenza A(H1N1) season in Sicily, April 2009-December 2010.
Tramuto F; Maida CM; Bonura F; Perna AM; Puzelli S; De Marco MA; Donatelli I; Aprea L; Firenze A; Arcadipane A; Palazzo U; Vitale F
Euro Surveill; 2011 Sep; 16(35):. PubMed ID: 21903041
[TBL] [Abstract][Full Text] [Related]
16. Vaccines against influenza A (H1N1) pandemic.
Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
[TBL] [Abstract][Full Text] [Related]
17. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination.
Kelly H; Grant K
Euro Surveill; 2009 Aug; 14(31):. PubMed ID: 19660248
[TBL] [Abstract][Full Text] [Related]
18. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
[TBL] [Abstract][Full Text] [Related]
19. Sustained low influenza vaccination in health care workers after H1N1 pandemic: a cross sectional study in an Italian health care setting for at-risk patients.
Giannattasio A; Mariano M; Romano R; Chiatto F; Liguoro I; Borgia G; Guarino A; Lo Vecchio A
BMC Infect Dis; 2015 Aug; 15():329. PubMed ID: 26265328
[TBL] [Abstract][Full Text] [Related]
20. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain.
Larrauri A; Savulescu C; Jiménez-Jorge S; Pérez-Breña P; Pozo F; Casas I; Ledesma J; de Mateo S;
Gac Sanit; 2011; 25(1):23-8. PubMed ID: 21334788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
